How much does tirzepatide cost on Wells Pharmacy Network?

Before launching a tirzepatide program, ask Wells Pharmacy Network for a written per-Rx cost estimate on tirzepatide as its own itemized line — not bundled into a general GLP-1 inquiry. Confirm cost across the dose ladder you prescribe, since tirzepatide also titrates and different doses can mean different vial sizes or concentrations with different per-Rx costs. Ask whether multi-month or larger vials change per-dose economics, and whether your cost is stable across refill cycles. If you run both semaglutide and tirzepatide, get both estimates side by side to see which drug carries better margin at your patient price points.

Patient demand shifts between the two molecules over time. If your cohort is migrating toward tirzepatide, a cost confirmed only on semaglutide leaves your fastest-growing line undefined. Pricing each GLP-1 SKU independently keeps your margin model accurate as the mix changes and patient cohorts mature past the intro dose on each drug.

Fizy Health shows resolved per-vial 503A cost for tirzepatide on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment — the same model it uses for semaglutide and every other SKU. Because each molecule and strength shows its own cost, you can compare tirzepatide and semaglutide economics directly and set patient pricing on numbers you can read before the consult, not after a first order cycle.

That makes a two-drug GLP-1 program easier to manage. You can model margin on each molecule across its titration ladder, see how the mix affects blended margin, and adjust patient pricing as demand shifts. Compare a visible tirzepatide per-vial cost on Fizy Health against any Wells per-Rx estimate on the same strength and vial size to confirm which model gives you clearer SKU-level economics.